NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology. (2017)
Attributed to:
Pathway-driven identification of therapeutic targets for combatting Alzheimer's disease.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.redox.2017.07.006
PubMed Identifier: 28704727
Publication URI: http://europepmc.org/abstract/MED/28704727
Type: Journal Article/Review
Volume: 13
Parent Publication: Redox biology
ISSN: 2213-2317